Understanding how proteins in cells respond to changes in lipid levels
The mechanistic basis for targeted protein degradation in lipid metabolism
This study is looking at how certain proteins in our cells help keep the right balance of fats in the body, focusing on special enzymes that help break down proteins when fat levels change, which could lead to new ways to understand and manage fat-related health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11088919 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which proteins in the endoplasmic reticulum (ER) of mammalian cells respond to changes in lipid composition. It focuses on the role of specific enzymes, known as E3 ligases, that tag proteins for degradation, which is crucial for maintaining lipid balance in the body. By studying how these enzymes interact with lipids and their substrates, the research aims to uncover new insights into lipid metabolism and its regulation. The approach involves a combination of cellular and biochemical assays to analyze the activity of these enzymes in relation to lipid levels.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with metabolic disorders that affect lipid metabolism, such as dyslipidemia or obesity.
Not a fit: Patients who do not have metabolic disorders or lipid metabolism issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for metabolic diseases related to lipid imbalances.
How similar studies have performed: While the specific focus on ER-localized E3 ligases and their role in lipid metabolism is relatively novel, similar approaches in studying protein degradation and lipid regulation have shown promise in other research.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Kober, Daniel Luke — Ut Southwestern Medical Center
- Study coordinator: Kober, Daniel Luke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.